Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs JUBILANT LIFE SCIENCES - Comparison Results

ALEMBIC     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC JUBILANT LIFE SCIENCES ALEMBIC/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 59.1 16.8 351.9% View Chart
P/BV x 5.1 3.1 162.5% View Chart
Dividend Yield % 0.2 0.5 42.1%  

Financials

 ALEMBIC   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ALEMBIC
Mar-18
JUBILANT LIFE SCIENCES
Mar-19
ALEMBIC/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs72898 8.0%   
Low Rs34618 5.5%   
Sales per share (Unadj.) Rs4.7572.0 0.8%  
Earnings per share (Unadj.) Rs6.136.2 16.8%  
Cash flow per share (Unadj.) Rs6.259.5 10.5%  
Dividends per share (Unadj.) Rs0.204.50 4.4%  
Dividend yield (eoy) %0.40.6 63.6%  
Book value per share (Unadj.) Rs40.7301.9 13.5%  
Shares outstanding (eoy) m267.03159.28 167.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.31.3 850.3%   
Avg P/E ratio x8.720.9 41.5%  
P/CF ratio (eoy) x8.512.7 66.6%  
Price / Book Value ratio x1.32.5 51.9%  
Dividend payout %3.312.4 26.4%   
Avg Mkt Cap Rs m14,139120,694 11.7%   
No. of employees `000NA2.4 0.0%   
Total wages/salary Rs m20719,260 1.1%   
Avg. sales/employee Rs ThNM38,120.6-  
Avg. wages/employee Rs ThNM8,058.4-  
Avg. net profit/employee Rs ThNM2,414.3-  
INCOME DATA
Net Sales Rs m1,25591,108 1.4%  
Other income Rs m370357 103.6%   
Total revenues Rs m1,62591,466 1.8%   
Gross profit Rs m11117,390 0.6%  
Depreciation Rs m383,709 1.0%   
Interest Rs m22,198 0.1%   
Profit before tax Rs m44211,840 3.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-2,802 0.0%   
Tax Rs m243,268 0.7%   
Profit after tax Rs m1,6305,770 28.2%  
Gross profit margin %8.919.1 46.4%  
Effective tax rate %5.427.6 19.6%   
Net profit margin %129.86.3 2,050.3%  
BALANCE SHEET DATA
Current assets Rs m1,86745,848 4.1%   
Current liabilities Rs m59120,897 2.8%   
Net working cap to sales %101.627.4 371.2%  
Current ratio x3.22.2 143.9%  
Inventory Days Days9457 166.0%  
Debtors Days Days7451 144.4%  
Net fixed assets Rs m1,79165,498 2.7%   
Share capital Rs m534159 335.3%   
"Free" reserves Rs m10,32447,930 21.5%   
Net worth Rs m10,85848,089 22.6%   
Long term debt Rs m4142,429 0.1%   
Total assets Rs m11,591114,685 10.1%  
Interest coverage x260.96.4 4,084.8%   
Debt to equity ratio x00.9 0.4%  
Sales to assets ratio x0.10.8 13.6%   
Return on assets %14.16.9 202.6%  
Return on equity %15.012.0 125.1%  
Return on capital %15.212.4 122.4%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1912,422 0.2%   
Fx outflow Rs m26417,227 1.5%   
Net fx Rs m-244-4,805 5.1%   
CASH FLOW
From Operations Rs m23611,215 2.1%  
From Investments Rs m-224-10,118 2.2%  
From Financial Activity Rs m-276,574 -0.4%  
Net Cashflow Rs m-157,612 -0.2%  

Share Holding

Indian Promoters % 64.0 45.6 140.4%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 0.2 8.7 2.3%  
FIIs % 9.7 21.2 45.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 21.1 123.7%  
Shareholders   54,701 23,815 229.7%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUVEN LIFE SCIENCES  SUN PHARMA  IPCA LABS  FDC  NEULAND LABS  

Compare ALEMBIC With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 470 Points Lower; Tata Motors & Tata Steel Fall 6%(Closing)

Indian share markets witnessed huge selling pressure today, in line with global equities and fell on to bearish territory.

Related Views on News

The BSE HEALTHCARE Index Down 2% ; DISHMAN CARBOGEN AMCIS Among Top Losers (Market Updates)

Jan 18, 2021 | Updated on Jan 18, 2021

The BSE HEALTHCARE Index Down at 22,079 (down 2.0%). Among the top losers in the BSE HEALTHCARE Index today are DISHMAN CARBOGEN AMCIS, JUBILANT LIFE SCIENCES and SHALBY . Meanwhile, the BSE Sensex has plunged 0.6% to 49,122.

TVS SRICHAKRA Share Price Down by 5%; BSE 500 Index Down 1.3% (Market Updates)

Jan 18, 2021 | Updated on Jan 18, 2021

TVS SRICHAKRA share price is trading down by 5% and its current market price is Rs 1,899. The BSE 500 is down by 1.3%. The top gainers in the BSE 500 Index are GSK CONSUMER (up 5.1%) and TATA ELXSI (up 4.8%). The top losers are TVS SRICHAKRA (down 5.1%) and JUBILANT LIFE SCIENCES (down 5.3%).

JUBILANT LIFE SCIENCES Share Price Down by 6%; BSE 500 Index Down 1.4% (Market Updates)

Jan 18, 2021 | Updated on Jan 18, 2021

JUBILANT LIFE SCIENCES share price is trading down by 6% and its current market price is Rs 989. The BSE 500 is down by 1.4%. The top gainers in the BSE 500 Index are GSK CONSUMER (up 5.1%) and TATA ELXSI (up 5.0%). The top losers are JUBILANT LIFE SCIENCES (down 5.7%) and GODREJ PROPERTIES (down 5.6%).

ALEMBIC LTD Announces Quarterly Results (1QFY21); Net Profit Up 3.5% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, ALEMBIC LTD has posted a net profit of Rs 21 m (up 3.5% YoY). Sales on the other hand came in at Rs 131 m (down 49.7% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC SHARE PRICE


Jan 18, 2021 (Close)

TRACK ALEMBIC

  • Track your investment in ALEMBIC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC - NEULAND LABS COMPARISON

COMPARE ALEMBIC WITH

MARKET STATS